This page gives a selection of surveys and studies for you to get involved in and to help drive COVID-19 research in LMICs

International Perinatal Outcomes in the Pandemic Study: iPOP Study

Preterm birth is the leading cause of infant mortality worldwide, but the underlying causes are largely unknown.

During the COVID-19 lockdowns, unprecedented reductions in preterm birth rates have been reported - although data from Nepal show an opposite trend, and increases in stillbirth. It is critical to evaluate these trends globally using high quality data, and to understand the underlying cause(s). Pandemic lockdowns have dramatically impacted maternal workload, access to healthcare, hygiene practices, and air pollution - all of which could impact perinatal outcomes and might differentially affect women in different regions of the world. We will seize the unique opportunity offered by the global COVID-19 pandemic to answer these urgent questions.

In the global iPOP study, the research team will investigate the impact of pandemic lockdowns on preterm birth and stillbirth, and assess the underlying causative factors.

The more centers are included, the more it can learnt!

If you have access to perinatal data (birth rates, gestational age and/or birth weight) at a national, regional or institutional level during the pandemic lockdown and 5 years prior, and would like to join the iPOP team, please contact Nicole Fiorentino with the subject line "Join iPOP" at


Participate in the Humanitarian GBV Risk Mitigation & COVID-19 Survey

The study includes a 30-minute online survey on gender-based violence (GBV) risk mitigation and COVID-19 in humanitarian settings. This survey is being conducted by researchers at Beth Israel Deaconess Medical Center, in partnership with UNICEF, CARE, and the Harvard Humanitarian Initiative (HHI). We encourage practitioners working in the humanitarian field, especially those in non-protection sectors, to participate in the survey available here in 6 languages. Your experiences and insights will help strengthen GBV risk mitigation in the context of COVID-19. 

For more information contact Dr. Jennifer Scott (Beth Israel Deaconess Medical Center) and the Humanitarian Gender Study Team at


COVID-19 Trauma Study

CovidTrauma is a research network to monitor how the current COVID-19 pandemic is impacting orthopaedic trauma services across Africa. It aims to promote cooperation as an orthopaedic community to tackle this unprecedented challenge. A snapshot study has been running from April-June 2020 with collaborators across Africa. We will be analysing results and share findings here as soon as possible.

If you have questions, please contact


 Open Call for COVID-19 resources in French, Spanish and Portuguese! 
Complete forms below to share your information

In observing the various countries response to COVID-19, resources in English are quite prevalent, while those in French, Spanish and Portuguese are not as widely known and disseminated.
In order to gather the largest amount of resources in these languages, we hereby ask for your help by sharing your resources. Your participation will incur no cost to you or to the institution that produced the resource, and there will be no financial compensation, but it may bring benefits such as increased audience, citation and recognition for the resource and for the institution itself. The Global Health Network has a global audience and thousands of people who seek resources to support their research.

Do you have research resources in French, Spanish or Portuguese you can share to support colleagues across the world?

If yes, please complete the COVID-19 Resource Sharing form below and email resources to

Thank you for your support in our mission to support equitable access to conducting research across the globe.

COVID-19: Formulario de intercambio de recursos para investigación

COVID-19: Formulário para compartilhamento de recursos para pesquisa

COVID-19: Resource Sharing Form

COVID-19: Formulaire de partage de ressources


ISARIC Data Initiative

ISARIC partnerships and outbreak preparedness initiatives has enabled the rapid launch of standardised clinical data collection on COVID-19 in Jan 2020. Since its launch, ISARIC has assembled data from more than 545 sites in 42 countries to create one of the world’s largest and richest COVID-19 clinical datasets (Pritchard, Dankwa et al. 2020).  The dataset now contains information on > 130,000 patients (as of Oct 2020).

In order to accelerate a collective understanding of COVID-19, to help improve patient care, and inform public health policy, ISARIC is opening the platform for analysis, from:

  • All those who have contributed data, as well as
  • Other interested groups/researchers keen to work on this rich dataset

In all instances, applications are to be made via submission of a Statistical Analysis Plan (SAP).

If successful, applicants will be partnered up with a member from the ISARIC Clinical/Analytical Group to collaborate with this research.